BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 34609081)

  • 21. The Interplay Among Pancreatic Cancer, Cachexia, Body Composition, and Diabetes.
    Dunne RF; Roeland EJ
    Hematol Oncol Clin North Am; 2022 Oct; 36(5):897-910. PubMed ID: 36154783
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Metabolic response to feeding in weight-losing pancreatic cancer patients and its modulation by a fish-oil-enriched nutritional supplement.
    Barber MD; McMillan DC; Preston T; Ross JA; Fearon KC
    Clin Sci (Lond); 2000 Apr; 98(4):389-99. PubMed ID: 10731472
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Impact on Health-Related Quality of Life of Parenteral Nutrition for Patients with Advanced Cancer Cachexia: Results from a Randomized Controlled Trial.
    Bouleuc C; Anota A; Cornet C; Grodard G; Thiery-Vuillemin A; Dubroeucq O; Crétineau N; Frasie V; Gamblin V; Chvetzoff G; Favier L; Tournigand C; Grach MC; Raynard B; Salas S; Capodano G; Pazart L; Aubry R
    Oncologist; 2020 May; 25(5):e843-e851. PubMed ID: 32212354
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Nutritional and immune impairments and their effects on outcomes in early pancreatic cancer patients undergoing pancreatoduodenectomy.
    Tumas J; Tumiene B; Jurkeviciene J; Jasiunas E; Sileikis A
    Clin Nutr; 2020 Nov; 39(11):3385-3394. PubMed ID: 32184025
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Early enteral nutrition within 24 hours of lower gastrointestinal surgery versus later commencement for length of hospital stay and postoperative complications.
    Herbert G; Perry R; Andersen HK; Atkinson C; Penfold C; Lewis SJ; Ness AR; Thomas S
    Cochrane Database Syst Rev; 2019 Jul; 7(7):CD004080. PubMed ID: 31329285
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Early enteral nutrition within 24 hours of lower gastrointestinal surgery versus later commencement for length of hospital stay and postoperative complications.
    Herbert G; Perry R; Andersen HK; Atkinson C; Penfold C; Lewis SJ; Ness AR; Thomas S
    Cochrane Database Syst Rev; 2018 Oct; 10(10):CD004080. PubMed ID: 30353940
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Sex specificity of pancreatic cancer cachexia phenotypes, mechanisms, and treatment in mice and humans: role of Activin.
    Zhong X; Narasimhan A; Silverman LM; Young AR; Shahda S; Liu S; Wan J; Liu Y; Koniaris LG; Zimmers TA
    J Cachexia Sarcopenia Muscle; 2022 Aug; 13(4):2146-2161. PubMed ID: 35510530
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Body weight changes and incidence of cachexia after stroke.
    Scherbakov N; Pietrock C; Sandek A; Ebner N; Valentova M; Springer J; Schefold JC; von Haehling S; Anker SD; Norman K; Haeusler KG; Doehner W
    J Cachexia Sarcopenia Muscle; 2019 Jun; 10(3):611-620. PubMed ID: 30680953
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Nutritional interventions for survivors of childhood cancer.
    Cohen JE; Wakefield CE; Cohn RJ
    Cochrane Database Syst Rev; 2016 Aug; 2016(8):CD009678. PubMed ID: 27545902
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Enteral tube feeding for people with severe dementia.
    Davies N; Barrado-Martín Y; Vickerstaff V; Rait G; Fukui A; Candy B; Smith CH; Manthorpe J; Moore KJ; Sampson EL
    Cochrane Database Syst Rev; 2021 Aug; 8(8):CD013503. PubMed ID: 34387363
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of bolus enteral tube feeding on body weight in ambulatory adults with obesity and type 2 diabetes: a feasibility pilot randomized trial.
    Beale EO; Lee W; Lee A; Lee C; Soffer E; Crookes PF; Eagilen K; Chen R; Mack WJ; Tong H
    Nutr Diabetes; 2020 Jun; 10(1):22. PubMed ID: 32555148
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The prognostic significance of patient-reported outcomes in pancreatic cancer cachexia.
    Robinson DW; Eisenberg DF; Cella D; Zhao N; de Boer C; DeWitte M
    J Support Oncol; 2008; 6(6):283-90. PubMed ID: 18724539
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Predictors of Pancreatic Cancer-Associated Weight Loss and Nutritional Interventions.
    Nemer L; Krishna SG; Shah ZK; Conwell DL; Cruz-Monserrate Z; Dillhoff M; Guttridge DC; Hinton A; Manilchuk A; Pawlik TM; Schmidt CR; Talbert EE; Bekaii-Saab T; Hart PA
    Pancreas; 2017 Oct; 46(9):1152-1157. PubMed ID: 28902785
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Heterogeneity of weight loss and transcriptomic signatures in pancreatic ductal adenocarcinoma.
    Riner AN; Herremans KM; Vudatha V; Han S; Qu X; Liu J; Mukhopadhyay N; Freudenberger DC; George TJ; Judge SM; Judge AR; Hughes SJ; Trevino JG
    J Cachexia Sarcopenia Muscle; 2024 Feb; 15(1):149-158. PubMed ID: 38123146
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of multimodal intervention care on cachexia in patients with advanced cancer compared to conventional management (MIRACLE): an open-label, parallel, randomized, phase 2 trial.
    Maeng CH; Kim BH; Chon J; Kang WS; Kang K; Woo M; Hong IK; Lee J; Lee KY
    Trials; 2022 Apr; 23(1):281. PubMed ID: 35410294
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Phase II study of the novel peptide-nucleic acid OHR118 in the management of cancer-related anorexia/cachexia.
    Chasen M; Hirschman SZ; Bhargava R
    J Am Med Dir Assoc; 2011 Jan; 12(1):62-7. PubMed ID: 21194662
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Parenteral versus enteral nutrition in cancer patients: indications and practice.
    Mercadante S
    Support Care Cancer; 1998 Mar; 6(2):85-93. PubMed ID: 9540165
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pancreatic cancer related cachexia: influence on metabolism and correlation to weight loss and pulmonary function.
    Bachmann J; Ketterer K; Marsch C; Fechtner K; Krakowski-Roosen H; Büchler MW; Friess H; Martignoni ME
    BMC Cancer; 2009 Jul; 9():255. PubMed ID: 19635171
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Nutritional status and feeding-tube placement in patients with locally advanced hypopharyngeal cancer included in an induction chemotherapy-based larynx preservation program.
    Bozec A; Benezery K; Chamorey E; Ettaiche M; Vandersteen C; Dassonville O; Poissonnet G; Riss JC; Hannoun-Lévi JM; Chand ME; Leysalle A; Saada E; Sudaka A; Haudebourg J; Hebert C; Falewee MN; Demard F; Santini J; Peyrade F
    Eur Arch Otorhinolaryngol; 2016 Sep; 273(9):2681-7. PubMed ID: 26395117
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.